Hydroxygenkwanin
CAS No. 20243-59-8
Hydroxygenkwanin( —— )
Catalog No. M18207 CAS No. 20243-59-8
Hydroxygenkwanin has cytotoxicity, may be an effective natural product to treat glioma, and the combination of Apigenin and Hydroxygenkwanin may be a promising method for glioma chemotherapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 153 | In Stock |
|
| 50MG | 223 | In Stock |
|
| 100MG | 332 | In Stock |
|
| 200MG | 490 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxygenkwanin
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxygenkwanin has cytotoxicity, may be an effective natural product to treat glioma, and the combination of Apigenin and Hydroxygenkwanin may be a promising method for glioma chemotherapy.
-
DescriptionHydroxygenkwanin possesses significant the antioxidative activity . Hydroxygenkwanin has cytotoxicity, may be an effective natural product to treat glioma, and the combination of Apigenin and Hydroxygenkwanin may be a promising method for glioma chemotherapy.
-
In VitroHydroxygenkwanin (7-O-Methylluteolin) inhibits C6 glioma cell proliferation in a dose dependent manner. Hydroxygenkwanin induces the cell cycle arrest by flow cytometry and inhibits colony formation ability and cell movement. Hydroxygenkwanin induces cell cycle arrest through p21 activation and causes intrinsic cell apoptosis pathway.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAntioxidant
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number20243-59-8
-
Formula Weight300.26
-
Molecular FormulaC16H12O6
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (33.30 mM)
-
SMILESCOC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-04859989 HCl
PF-04859989 HCl is a brain-penetrable and irreversible inhibitor of kynurenine amino transferase II (KAT II), which is the enzyme responsible for most of the brain synthesis of kynurenic acid.
-
[Ala92]-p16 (84-103)
Peptide derived from the tumor suppressor protein p16; inhibits cyclin-dependent kinase-4 (cdk4)/cyclin D1 (IC50 ~ 1.5 μM) and binds to cdk6.
-
Cabazitaxel Impurity...
(4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid a.k.a. polyene-paclitaxel side chain is used as a pharmaceutical intermediate mainly for synthesizing the drug polyene-paclitaxel.
Cart
sales@molnova.com